| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JGM.739 |
| P698 | PubMed publication ID | 15756649 |
| P50 | author | Myra McClure | Q59550553 |
| Michael J McGarvey | Q62560701 | ||
| Rebecca A Russell | Q63367460 | ||
| P2093 | author name string | Bryan R Cullen | |
| Michael D Moore | |||
| P2860 | cites work | Properties of human foamy virus relevant to its development as a vector for gene therapy | Q28143281 |
| Characterization of a newly derived human sarcoma cell line (HT-1080). | Q34202593 | ||
| Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. | Q34596607 | ||
| Effect of vector-expressed siRNA on HBV replication in hepatoblastoma cells | Q36065871 | ||
| Inhibition of human La protein by RNA interference downregulates hepatitis B virus mRNA in 2.2.15 cells | Q36066199 | ||
| siRNA-mediated inhibition of HBV replication and expression | Q40513757 | ||
| Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference | Q40695522 | ||
| P433 | issue | 7 | |
| P921 | main subject | Hepatitis B virus | Q6844 |
| vector-borne disease | Q2083837 | ||
| P304 | page(s) | 918-925 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Journal of Gene Medicine | Q15746377 |
| P1476 | title | Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. | |
| P478 | volume | 7 |
| Q47574790 | Advanced Strategies for Eliminating the cccDNA of HBV. |
| Q92702144 | Calcium Phosphate Nanoparticles-Based Systems for RNAi Delivery: Applications in Bone Tissue Regeneration |
| Q40187057 | Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors |
| Q25256708 | Criteria for effective design, construction, and gene knockdown by shRNA vectors |
| Q42054773 | Efficient liver gene transfer with foamy virus vectors |
| Q33819100 | Enhanced antiviral and antifibrotic effects of short hairpin RNAs targeting HBV and TGF-β in HBV-persistent mice |
| Q40327702 | EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs |
| Q38366585 | Gene therapeutic approaches to inhibit hepatitis B virus replication |
| Q34123971 | Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells |
| Q37137539 | Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro |
| Q36483991 | Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference |
| Q35186003 | Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells |
| Q42235235 | Inhibition of hepatitis B virus cccDNA by siRNA in transgenic mice |
| Q40202408 | Knockdown of mouse VCAM-1 by vector-based siRNA. |
| Q26859021 | Lipid nanoparticles as carriers for RNAi against viral infections: current status and future perspectives |
| Q36852196 | Opportunities for treating chronic hepatitis B and C virus infection using RNA interference |
| Q33653027 | RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo |
| Q36944914 | RNA interference and antiviral therapy. |
| Q36412870 | RNAi for treating hepatitis B viral infection |
| Q33455759 | Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. |
| Q36384459 | Therapeutic short hairpin RNA expression in the liver: viral targets and vectors |
| Q39979308 | Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts |
| Q34471754 | Viral-based modelling and correction of neurodegenerative diseases by RNA interference. |
Search more.